文献速递主动脉外科

左锁骨下动脉原位开窗在2区TEVAR中的初步经验

Preliminary experience of the isolate left subclavian artery in-situ fenestration during 'zone 2' thoracic endovascular aortic repair.
PubMed 文献 · Eur J Cardiothorac Surg · 2024-01-01

多中心回顾性队列研究纳入50例接受2区TEVAR并孤立左锁骨下动脉血运重建的患者,使用新型可调穿刺针系统行原位开窗。手术技术成功47例(94.0%),无手术死亡,30天死亡1例(2.0%,非主动脉相关),随访中桥接支架通畅率100%,无开窗相关内漏或再干预。

要点

  • 2区TEVAR中孤立左锁骨下动脉原位开窗技术成功率高(94.0%),无手术死亡。
  • 中位开窗时间20分钟,中位手术时间184分钟,随访桥接支架通畅率100%。
  • 30天死亡1例(2.0%,非主动脉相关),无开窗相关内漏或再干预。

核心结论

  • 使用Ankura™-II装置及自定心可调穿刺针系统行原位开窗TEVAR技术成功率高,稳定性和主动脉相关结果良好,是标准2区TEVAR安全有效的替代方案。

研究设计与样本

  • 多中心、回顾性、研究者发起的队列研究,纳入2021年7月28日至2024年4月3日接受择期或紧急/急诊2区TEVAR并孤立左锁骨下动脉血运重建的50例患者。

主要发现

  • 50例中动脉粥样硬化性胸主动脉瘤28例(56.0%),B型主动脉夹层12例(24.0%),穿透性主动脉溃疡10例(20.0%);择期干预46例(92.0%)。
  • 原位开窗全部成功,手术主要技术成功47例(94.0%);中位手术时间184分钟(IQR 135-220),中位开窗时间20分钟(IQR 13-35)。
  • 无手术死亡;观察到脊髓缺血1例,双侧后循环非致残性卒中2例;30天死亡1例(2.0%,非主动脉相关)。
  • 中位随访4个月(IQR 1-12.25),桥接支架通畅率100%,无开窗相关内漏,无需开窗相关再干预。

临床怎么用

  • 对于需要2区TEVAR并需保留左锁骨下动脉血运的患者,使用Ankura™-II装置及自定心可调穿刺针系统行原位开窗可作为标准2区TEVAR的替代选择。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To evaluate the results of isolated left subclavian artery in-situ fenestration (ISF) during 'zone 2' thoracic endovascular aortic repair (TEVAR) using a new adjustable needle puncturing device system. METHODS: It is a multicentre, retrospective, physician-initiated cohort study of patients treated from 28 July 2021 to 3 April 2024. Inclusion criteria were isolate left subclavian artery revascularization for elective or urgent/emergent 'zone 2' TEVAR. The primary outcome was technical success and freedom from ISF TEVAR-related reintervention or endoleak. RESULTS: We treated 50 patients: 28 (56.0%) atherosclerotic thoracic aneurysms, 12 (24.0%) type B aortic dissection and 10 (20.0%) penetrating aortic ulcers. Elective intervention was carried out in 46 (92.0%) cases. ISF was successful in all cases, with a procedural primary technical success in 47 (94.0%) cases. The median time of intervention was 184 min (interquartile range 135-220) with a median fenestration time of 20 min (interquartile range 13-35). Operative mortality did not occur. We observed 1 case of spinal cord ischaemia and 2 cases of bilateral posterior non-disabling stroke. Mortality at 30 days occurred in 1 (2.0%) patient (not aorta-related). The median follow-up was 4 months (interquartile range 1-12.25). Bridging stent graft patency was 100% with no ISF-related endoleak. ISF-related reintervention was never required. CONCLUSIONS: ISF TEVAR using the Ankura™-II device with the self-centring adjustable needle system showed high technical success, promising stability and stable aortic-related outcomes. Owing to these results, it represents a safe and effective alternative for standard 'zone 2' TEVAR.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Piffaretti G, Gaggiano A, Pratesi G, et al. Preliminary experience of the isolate left subclavian artery in-situ fenestration during 'zone 2' thoracic endovascular aortic repair. Eur J Cardiothorac Surg. 2024. PMID: 39254638. doi:10.1093/ejcts/ezae332

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。